Red Light Holland To Consult PharmAla On Developing Medical Psilocybin
Red Light Holland (CSE: TRIP) is making moves to enter the clinical side of psilocybin, announcing this morning that it
Read moreRed Light Holland (CSE: TRIP) is making moves to enter the clinical side of psilocybin, announcing this morning that it
Read moreEvidently there is big money within the mushroom market. Red Light Holland (CSE: TRIP) this morning indicated it is dropping
Read moreJoining back on the Daily Dive is Bruce Linton, founder and former CEO of Canopy Growth Corporation (TSX: WEED). He
Read moreRed Light Holland (CSE: TRIP) and Creso Pharma (ASX: CPH) evidently have elected to walk from their previously announced merger
Read moreCreso Pharma (ASX: CPH) this morning announced that it is set to merge with that of Red Light Holland (CSE:
Read moreRed Light Holland (CSE: TRIP) this morning reported that it has seen the successful sale and import of its psychedelic
Read moreLess than a month after its last bought deal, Red Light Holland (CSE: TRIP) has announced another financing. The company
Read moreRed Light Holland (CSE: TRIP) is looking to add to its war chest with the announcement this morning that the
Read moreRed Light Holland (CSE: TRIP) is evidently cashed up as a result of the recent rise in its equity price.
Read moreRed Light Holland (CSE: TRIP) has commenced growing 1,000 kilograms of magic truffles. The company made the announcement this morning,
Read more